These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34528880)

  • 1. Impact of Socioeconomic Factors on Prognosis and Clinical Management in Patients with Hepatocellular Carcinoma.
    Su BB; Zhou BH; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
    Turk J Gastroenterol; 2021 Aug; 32(8):667-677. PubMed ID: 34528880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Socioeconomic Status on Staging, Prognosis in Hepatocellular Carcinoma.
    Zhou Y; Zhang W; Ma J; Zhang Z; Yang M; Luo J; Yan Z
    Int J Gen Med; 2022; 15():1459-1469. PubMed ID: 35210820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
    Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
    Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center.
    Kee KM; Wang JH; Lin CY; Wang CC; Cheng YF; Lu SN
    Dig Dis Sci; 2013 Sep; 58(9):2721-8. PubMed ID: 23703450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world clinical significance of nonbiological factors with staging, prognosis and clinical management in rectal cancer.
    Gao TM; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
    Eur J Surg Oncol; 2021 May; 47(5):990-998. PubMed ID: 33046280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
    Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
    BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer.
    Huang Y; Sheng H; Zhang J; Liu Q; Ye D; Shi G
    World J Urol; 2019 Oct; 37(10):2165-2173. PubMed ID: 30554272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of marital status on the survival of patients with hepatocellular carcinoma treated with surgical resection: an analysis of 13,408 patients in the surveillance, epidemiology, and end results (SEER) database.
    Wu C; Chen P; Qian JJ; Jin SJ; Yao J; Wang XD; Bai DS; Jiang GQ
    Oncotarget; 2016 Nov; 7(48):79442-79452. PubMed ID: 27769053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma.
    Qiao CX; Zhai XF; Ling CQ; Lang QB; Dong HJ; Liu Q; Li MD
    World J Gastroenterol; 2012 Jun; 18(21):2689-94. PubMed ID: 22690079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-world study of socioeconomic factors with survival in adults aged 18-64 years with renal cell carcinoma.
    Zhang SL; Zhang ZY; Liu ZJ; Wang WR; Li ZM; Han B; Wang X; Wang LS
    Future Oncol; 2019 Jul; 15(21):2503-2515. PubMed ID: 31240959
    [No Abstract]   [Full Text] [Related]  

  • 12. The growth rate of hepatocellular carcinoma is different with different TNM stages at diagnosis.
    Gao TM; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):330-336. PubMed ID: 33637452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of new TNM staging system for hepatocellular carcinoma after hepatectomy].
    Li BK; Cui BK; Yuan YF; Li JQ; Zhang YQ; Shi M; Li GH
    Ai Zheng; 2005 Jul; 24(7):769-73. PubMed ID: 16004798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
    Chen LJ; Chang YJ; Chang YJ
    Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Implications of Nonbiological Factors with Staging, Prognosis and Clinical Management in Colon Cancer.
    Liu Q; Luo D; Cai S; Li Q; Li X
    Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30096811
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between socioeconomic status and survival in patients with hepatocellular carcinoma.
    Zheng Y; Zhang X; Lu J; Liu S; Qian Y
    Cancer Med; 2021 Oct; 10(20):7347-7359. PubMed ID: 34414679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery.
    Xu LB; Wang J; Liu C; Pang HW; Chen YJ; Ou QJ; Chen JS
    World J Gastroenterol; 2010 Nov; 16(41):5257-62. PubMed ID: 21049561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
    Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
    PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.
    Leung TW; Tang AM; Zee B; Lau WY; Lai PB; Leung KL; Lau JT; Yu SC; Johnson PJ
    Cancer; 2002 Mar; 94(6):1760-9. PubMed ID: 11920539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.